Table 3.
Multiple logistic regression analysis on AISC in acute leukemia patients completed 3 cycles of chemotherapy
| Characteristics | OR (95%CI)(Adjusted) | P-value |
|---|---|---|
| Age, per 1 year | 0.985(0.923, 1.051) | 0.985 |
| Gender, yes versus no | 0.784(0.181, 3.408) | 0.746 |
| UA,per 1 mmol/L | 1.005(0.999, 1.012) | 0.102 |
| PLT,per 1*109/L | 1.012(1.002, 1.021) | 0.016 |
| E,per 1 cm/s | 1.014(0.972, 3.408) | 0.516 |
| e’, per 1 cm/s | 1.195(0.691, 2.067) | 0.524 |
| DBil,per 1µmol/L | 0.612(0.409, 0.916) | 0.017 |
| TBil,per 1µmol/L | 0.841(0.717, 0.986) | 0.033 |
| Glu,per 1mmol/L | 1.873(1.009, 3.475) | 0.047 |
AISC:anthracycline-induced subclinical cardiotoxicity; OR (95% CI), odds ratio (95% confidence interval); UA:uric acid; PLT:platelets; E:mitral inflow E velocity; e’:mitral e’ velocity; DBil:direct bilirubin; TBil:total bilirubin; Glu:glucose
Significant result (P < 0.05)